Retrospective Analysis of Corticosteroid Treatment in Stevens-Johnson Syndrome and/or Toxic Epidermal Necrolysis over a Period of 10 Years in Vajira Hospital, Navamindradhiraj University, Bangkok

Table 2

Percentage of intravenous steroid usage in Stevens-Johnson syndrome and/or toxic epidermal necrolysis patients stratified by SCORTEN.

	2008–2012; (𝑛=51)	2003–2007; (𝑛=36)
SCORTEN
≤1	87.5%	15.4%
2	63.1%	13.0%
3	83.3%	33.3%
4	100%	0%
≥5	66.7%	—